Indian Pharmas Anticipate Added Access To Japan’s Generics Market
This article was originally published in PharmAsia News
Executive Summary
Indian drug makers are looking forward to increased access to the world's second-largest pharmaceutical market, in Japan. Indian pharmas major in making generic drugs, which dovetails with the Japanese government's new emphasis on encouraging lower-cost drugs. But that access relies in part on a two-year-old comprehensive economic agreement the two nations have been negotiating. Those negotiations, expected to ease technology transfer, have been delayed recently as India puts a new government together in the wake of elections. (Click here for more